世界の全身性抗ヒスタミン薬市場予測 2023年-2029年

【英語タイトル】Global Systemic Antihistamines Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC00666)・商品コード:LP23DC00666
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の全身性抗ヒスタミン薬市場」は、過去の販売実績から2022年の世界の全身性抗ヒスタミン薬の総販売量を検討し、2023年から2029年の予測される全身性抗ヒスタミン薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の全身性抗ヒスタミン薬の市場規模を掲載し、XXX百万米ドル規模の世界の全身性抗ヒスタミン薬市場の詳細な分析を提供します。本インサイトレポートは、世界の全身性抗ヒスタミン薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の全身性抗ヒスタミン薬市場における各社の独自のポジションをより深く理解するために、全身性抗ヒスタミン薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の全身性抗ヒスタミン薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。全身性抗ヒスタミン薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。全身性抗ヒスタミン薬の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。全身性抗ヒスタミン薬のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

全身性抗ヒスタミン薬の世界主要メーカーとしては、Bristol-Myers Squibb、 Baxter Healthcare、 Watson Laboratories、 Pfizer、 Nexgen Pharma、 Bayer、 Hennig Arzneimittel、 Novartis、 Apotex、 Teva、 Mylan、 Johnson and Johnson、 Neuraxpharm Arzneimittel、 Gedeon Richter、 Medrock Biotechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の全身性抗ヒスタミン薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では全身性抗ヒスタミン薬市場をセグメンテーションし、種類別 (先発医薬品、ジェネリック医薬品)、用途別 (病院、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:先発医薬品、ジェネリック医薬品

・用途別区分:病院、薬局、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の全身性抗ヒスタミン薬市場の10年間の市場状況・展望は?
・世界および地域別に見た全身性抗ヒスタミン薬市場成長の要因は何か?
・全身性抗ヒスタミン薬の市場機会はエンドマーケットの規模によってどのように変化するのか?
・全身性抗ヒスタミン薬のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:全身性抗ヒスタミン薬の年間販売量2018-2029、地域別現状・将来分析
・全身性抗ヒスタミン薬の種類別セグメント:先発医薬品、ジェネリック医薬品
・全身性抗ヒスタミン薬の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・全身性抗ヒスタミン薬の用途別セグメント:病院、薬局、その他
・全身性抗ヒスタミン薬の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の全身性抗ヒスタミン薬市場
・企業別のグローバル全身性抗ヒスタミン薬市場データ:2018-2023年の年間販売量、市場シェア
・企業別の全身性抗ヒスタミン薬の年間売上:2018-2023年の売上、市場シェア
・企業別の全身性抗ヒスタミン薬販売価格
・主要企業の全身性抗ヒスタミン薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

全身性抗ヒスタミン薬の地域別レビュー
・地域別の全身性抗ヒスタミン薬市場規模2018-2023:年間販売量、売上
・主要国別の全身性抗ヒスタミン薬市場規模2018-2023:年間販売量、売上
・南北アメリカの全身性抗ヒスタミン薬販売の成長
・アジア太平洋の全身性抗ヒスタミン薬販売の成長
・ヨーロッパの全身性抗ヒスタミン薬販売の成長
・中東・アフリカの全身性抗ヒスタミン薬販売の成長

南北アメリカ市場
・南北アメリカの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・南北アメリカの全身性抗ヒスタミン薬の種類別販売量
・南北アメリカの全身性抗ヒスタミン薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・アジア太平洋の全身性抗ヒスタミン薬の種類別販売量
・アジア太平洋の全身性抗ヒスタミン薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・ヨーロッパの全身性抗ヒスタミン薬の種類別販売量
・ヨーロッパの全身性抗ヒスタミン薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・中東・アフリカの全身性抗ヒスタミン薬の種類別販売量
・中東・アフリカの全身性抗ヒスタミン薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・全身性抗ヒスタミン薬の製造コスト構造分析
・全身性抗ヒスタミン薬の製造プロセス分析
・全身性抗ヒスタミン薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・全身性抗ヒスタミン薬の主要なグローバル販売業者
・全身性抗ヒスタミン薬の主要なグローバル顧客

地域別の全身性抗ヒスタミン薬市場予測レビュー
・地域別の全身性抗ヒスタミン薬市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・全身性抗ヒスタミン薬の種類別市場規模予測
・全身性抗ヒスタミン薬の用途別市場規模予測

主要企業分析
Bristol-Myers Squibb、 Baxter Healthcare、 Watson Laboratories、 Pfizer、 Nexgen Pharma、 Bayer、 Hennig Arzneimittel、 Novartis、 Apotex、 Teva、 Mylan、 Johnson and Johnson、 Neuraxpharm Arzneimittel、 Gedeon Richter、 Medrock Biotech
・企業情報
・全身性抗ヒスタミン薬製品
・全身性抗ヒスタミン薬販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Systemic Antihistamines market size is projected to grow from US$ 25050 million in 2022 to US$ 38490 million in 2029; it is expected to grow at a CAGR of 6.3% from 2023 to 2029.
United States market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Antihistamines players cover Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Bayer, Hennig Arzneimittel, Novartis and Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Systemic antihistamines are a class of medications that are taken orally or administered through injection and are designed to block the effects of histamine throughout the body. Histamine is a chemical released by the immune system in response to an allergen, and it contributes to the symptoms of allergic reactions such as itching, sneezing, runny nose, hives, and swelling.
LPI (LP Information)’ newest research report, the “Systemic Antihistamines Industry Forecast” looks at past sales and reviews total world Systemic Antihistamines sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Antihistamines sales for 2023 through 2029. With Systemic Antihistamines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Antihistamines industry.
This Insight Report provides a comprehensive analysis of the global Systemic Antihistamines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Antihistamines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Antihistamines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Antihistamines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Antihistamines.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Antihistamines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Original Drug
Generic Drugs
Segmentation by application
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Bayer
Hennig Arzneimittel
Novartis
Apotex
Teva
Mylan
Johnson and Johnson
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Systemic Antihistamines market?
What factors are driving Systemic Antihistamines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Systemic Antihistamines market opportunities vary by end market size?
How does Systemic Antihistamines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Systemic Antihistamines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Systemic Antihistamines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Systemic Antihistamines by Country/Region, 2018, 2022 & 2029
2.2 Systemic Antihistamines Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drugs
2.3 Systemic Antihistamines Sales by Type
2.3.1 Global Systemic Antihistamines Sales Market Share by Type (2018-2023)
2.3.2 Global Systemic Antihistamines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Systemic Antihistamines Sale Price by Type (2018-2023)
2.4 Systemic Antihistamines Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Systemic Antihistamines Sales by Application
2.5.1 Global Systemic Antihistamines Sale Market Share by Application (2018-2023)
2.5.2 Global Systemic Antihistamines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Systemic Antihistamines Sale Price by Application (2018-2023)
3 Global Systemic Antihistamines by Company
3.1 Global Systemic Antihistamines Breakdown Data by Company
3.1.1 Global Systemic Antihistamines Annual Sales by Company (2018-2023)
3.1.2 Global Systemic Antihistamines Sales Market Share by Company (2018-2023)
3.2 Global Systemic Antihistamines Annual Revenue by Company (2018-2023)
3.2.1 Global Systemic Antihistamines Revenue by Company (2018-2023)
3.2.2 Global Systemic Antihistamines Revenue Market Share by Company (2018-2023)
3.3 Global Systemic Antihistamines Sale Price by Company
3.4 Key Manufacturers Systemic Antihistamines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Systemic Antihistamines Product Location Distribution
3.4.2 Players Systemic Antihistamines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Systemic Antihistamines by Geographic Region
4.1 World Historic Systemic Antihistamines Market Size by Geographic Region (2018-2023)
4.1.1 Global Systemic Antihistamines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Systemic Antihistamines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Systemic Antihistamines Market Size by Country/Region (2018-2023)
4.2.1 Global Systemic Antihistamines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Systemic Antihistamines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Systemic Antihistamines Sales Growth
4.4 APAC Systemic Antihistamines Sales Growth
4.5 Europe Systemic Antihistamines Sales Growth
4.6 Middle East & Africa Systemic Antihistamines Sales Growth
5 Americas
5.1 Americas Systemic Antihistamines Sales by Country
5.1.1 Americas Systemic Antihistamines Sales by Country (2018-2023)
5.1.2 Americas Systemic Antihistamines Revenue by Country (2018-2023)
5.2 Americas Systemic Antihistamines Sales by Type
5.3 Americas Systemic Antihistamines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Systemic Antihistamines Sales by Region
6.1.1 APAC Systemic Antihistamines Sales by Region (2018-2023)
6.1.2 APAC Systemic Antihistamines Revenue by Region (2018-2023)
6.2 APAC Systemic Antihistamines Sales by Type
6.3 APAC Systemic Antihistamines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Systemic Antihistamines by Country
7.1.1 Europe Systemic Antihistamines Sales by Country (2018-2023)
7.1.2 Europe Systemic Antihistamines Revenue by Country (2018-2023)
7.2 Europe Systemic Antihistamines Sales by Type
7.3 Europe Systemic Antihistamines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Systemic Antihistamines by Country
8.1.1 Middle East & Africa Systemic Antihistamines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Systemic Antihistamines Revenue by Country (2018-2023)
8.2 Middle East & Africa Systemic Antihistamines Sales by Type
8.3 Middle East & Africa Systemic Antihistamines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Systemic Antihistamines
10.3 Manufacturing Process Analysis of Systemic Antihistamines
10.4 Industry Chain Structure of Systemic Antihistamines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Systemic Antihistamines Distributors
11.3 Systemic Antihistamines Customer
12 World Forecast Review for Systemic Antihistamines by Geographic Region
12.1 Global Systemic Antihistamines Market Size Forecast by Region
12.1.1 Global Systemic Antihistamines Forecast by Region (2024-2029)
12.1.2 Global Systemic Antihistamines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Systemic Antihistamines Forecast by Type
12.7 Global Systemic Antihistamines Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Systemic Antihistamines Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Baxter Healthcare
13.2.1 Baxter Healthcare Company Information
13.2.2 Baxter Healthcare Systemic Antihistamines Product Portfolios and Specifications
13.2.3 Baxter Healthcare Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Healthcare Main Business Overview
13.2.5 Baxter Healthcare Latest Developments
13.3 Watson Laboratories
13.3.1 Watson Laboratories Company Information
13.3.2 Watson Laboratories Systemic Antihistamines Product Portfolios and Specifications
13.3.3 Watson Laboratories Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Watson Laboratories Main Business Overview
13.3.5 Watson Laboratories Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Systemic Antihistamines Product Portfolios and Specifications
13.4.3 Pfizer Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Nexgen Pharma
13.5.1 Nexgen Pharma Company Information
13.5.2 Nexgen Pharma Systemic Antihistamines Product Portfolios and Specifications
13.5.3 Nexgen Pharma Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nexgen Pharma Main Business Overview
13.5.5 Nexgen Pharma Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Systemic Antihistamines Product Portfolios and Specifications
13.6.3 Bayer Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Hennig Arzneimittel
13.7.1 Hennig Arzneimittel Company Information
13.7.2 Hennig Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
13.7.3 Hennig Arzneimittel Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hennig Arzneimittel Main Business Overview
13.7.5 Hennig Arzneimittel Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Systemic Antihistamines Product Portfolios and Specifications
13.8.3 Novartis Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Systemic Antihistamines Product Portfolios and Specifications
13.9.3 Apotex Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Systemic Antihistamines Product Portfolios and Specifications
13.10.3 Teva Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Systemic Antihistamines Product Portfolios and Specifications
13.11.3 Mylan Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Johnson and Johnson
13.12.1 Johnson and Johnson Company Information
13.12.2 Johnson and Johnson Systemic Antihistamines Product Portfolios and Specifications
13.12.3 Johnson and Johnson Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Johnson and Johnson Main Business Overview
13.12.5 Johnson and Johnson Latest Developments
13.13 Neuraxpharm Arzneimittel
13.13.1 Neuraxpharm Arzneimittel Company Information
13.13.2 Neuraxpharm Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
13.13.3 Neuraxpharm Arzneimittel Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Neuraxpharm Arzneimittel Main Business Overview
13.13.5 Neuraxpharm Arzneimittel Latest Developments
13.14 Gedeon Richter
13.14.1 Gedeon Richter Company Information
13.14.2 Gedeon Richter Systemic Antihistamines Product Portfolios and Specifications
13.14.3 Gedeon Richter Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Gedeon Richter Main Business Overview
13.14.5 Gedeon Richter Latest Developments
13.15 Medrock Biotech
13.15.1 Medrock Biotech Company Information
13.15.2 Medrock Biotech Systemic Antihistamines Product Portfolios and Specifications
13.15.3 Medrock Biotech Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Medrock Biotech Main Business Overview
13.15.5 Medrock Biotech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Systemic Antihistamines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Systemic Antihistamines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drugs
Table 5. Global Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 6. Global Systemic Antihistamines Sales Market Share by Type (2018-2023)
Table 7. Global Systemic Antihistamines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Systemic Antihistamines Revenue Market Share by Type (2018-2023)
Table 9. Global Systemic Antihistamines Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 11. Global Systemic Antihistamines Sales Market Share by Application (2018-2023)
Table 12. Global Systemic Antihistamines Revenue by Application (2018-2023)
Table 13. Global Systemic Antihistamines Revenue Market Share by Application (2018-2023)
Table 14. Global Systemic Antihistamines Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Systemic Antihistamines Sales by Company (2018-2023) & (K Units)
Table 16. Global Systemic Antihistamines Sales Market Share by Company (2018-2023)
Table 17. Global Systemic Antihistamines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Systemic Antihistamines Revenue Market Share by Company (2018-2023)
Table 19. Global Systemic Antihistamines Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Systemic Antihistamines Producing Area Distribution and Sales Area
Table 21. Players Systemic Antihistamines Products Offered
Table 22. Systemic Antihistamines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Systemic Antihistamines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Systemic Antihistamines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Systemic Antihistamines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Systemic Antihistamines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Systemic Antihistamines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Systemic Antihistamines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Systemic Antihistamines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Systemic Antihistamines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 35. Americas Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 37. Americas Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Systemic Antihistamines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Systemic Antihistamines Sales Market Share by Region (2018-2023)
Table 41. APAC Systemic Antihistamines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Systemic Antihistamines Revenue Market Share by Region (2018-2023)
Table 43. APAC Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 47. Europe Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 49. Europe Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Systemic Antihistamines
Table 58. Key Market Challenges & Risks of Systemic Antihistamines
Table 59. Key Industry Trends of Systemic Antihistamines
Table 60. Systemic Antihistamines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Systemic Antihistamines Distributors List
Table 63. Systemic Antihistamines Customer List
Table 64. Global Systemic Antihistamines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Systemic Antihistamines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Systemic Antihistamines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Systemic Antihistamines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Systemic Antihistamines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Systemic Antihistamines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Systemic Antihistamines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Systemic Antihistamines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bristol-Myers Squibb Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol-Myers Squibb Systemic Antihistamines Product Portfolios and Specifications
Table 80. Bristol-Myers Squibb Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. Baxter Healthcare Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Healthcare Systemic Antihistamines Product Portfolios and Specifications
Table 85. Baxter Healthcare Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter Healthcare Main Business
Table 87. Baxter Healthcare Latest Developments
Table 88. Watson Laboratories Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 89. Watson Laboratories Systemic Antihistamines Product Portfolios and Specifications
Table 90. Watson Laboratories Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Watson Laboratories Main Business
Table 92. Watson Laboratories Latest Developments
Table 93. Pfizer Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Systemic Antihistamines Product Portfolios and Specifications
Table 95. Pfizer Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Nexgen Pharma Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 99. Nexgen Pharma Systemic Antihistamines Product Portfolios and Specifications
Table 100. Nexgen Pharma Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Nexgen Pharma Main Business
Table 102. Nexgen Pharma Latest Developments
Table 103. Bayer Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Systemic Antihistamines Product Portfolios and Specifications
Table 105. Bayer Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Hennig Arzneimittel Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 109. Hennig Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
Table 110. Hennig Arzneimittel Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Hennig Arzneimittel Main Business
Table 112. Hennig Arzneimittel Latest Developments
Table 113. Novartis Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Systemic Antihistamines Product Portfolios and Specifications
Table 115. Novartis Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Apotex Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Systemic Antihistamines Product Portfolios and Specifications
Table 120. Apotex Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Apotex Main Business
Table 122. Apotex Latest Developments
Table 123. Teva Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Systemic Antihistamines Product Portfolios and Specifications
Table 125. Teva Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Teva Main Business
Table 127. Teva Latest Developments
Table 128. Mylan Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Systemic Antihistamines Product Portfolios and Specifications
Table 130. Mylan Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Mylan Main Business
Table 132. Mylan Latest Developments
Table 133. Johnson and Johnson Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 134. Johnson and Johnson Systemic Antihistamines Product Portfolios and Specifications
Table 135. Johnson and Johnson Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Johnson and Johnson Main Business
Table 137. Johnson and Johnson Latest Developments
Table 138. Neuraxpharm Arzneimittel Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 139. Neuraxpharm Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
Table 140. Neuraxpharm Arzneimittel Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Neuraxpharm Arzneimittel Main Business
Table 142. Neuraxpharm Arzneimittel Latest Developments
Table 143. Gedeon Richter Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 144. Gedeon Richter Systemic Antihistamines Product Portfolios and Specifications
Table 145. Gedeon Richter Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Gedeon Richter Main Business
Table 147. Gedeon Richter Latest Developments
Table 148. Medrock Biotech Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 149. Medrock Biotech Systemic Antihistamines Product Portfolios and Specifications
Table 150. Medrock Biotech Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Medrock Biotech Main Business
Table 152. Medrock Biotech Latest Developments
List of Figures
Figure 1. Picture of Systemic Antihistamines
Figure 2. Systemic Antihistamines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Systemic Antihistamines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Systemic Antihistamines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Systemic Antihistamines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drug
Figure 10. Product Picture of Generic Drugs
Figure 11. Global Systemic Antihistamines Sales Market Share by Type in 2022
Figure 12. Global Systemic Antihistamines Revenue Market Share by Type (2018-2023)
Figure 13. Systemic Antihistamines Consumed in Hospital
Figure 14. Global Systemic Antihistamines Market: Hospital (2018-2023) & (K Units)
Figure 15. Systemic Antihistamines Consumed in Retail Pharmacy
Figure 16. Global Systemic Antihistamines Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 17. Systemic Antihistamines Consumed in Other
Figure 18. Global Systemic Antihistamines Market: Other (2018-2023) & (K Units)
Figure 19. Global Systemic Antihistamines Sales Market Share by Application (2022)
Figure 20. Global Systemic Antihistamines Revenue Market Share by Application in 2022
Figure 21. Systemic Antihistamines Sales Market by Company in 2022 (K Units)
Figure 22. Global Systemic Antihistamines Sales Market Share by Company in 2022
Figure 23. Systemic Antihistamines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Systemic Antihistamines Revenue Market Share by Company in 2022
Figure 25. Global Systemic Antihistamines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Systemic Antihistamines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 28. Americas Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 30. APAC Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 32. Europe Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Systemic Antihistamines Sales Market Share by Country in 2022
Figure 36. Americas Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 37. Americas Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 38. Americas Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 39. United States Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Systemic Antihistamines Sales Market Share by Region in 2022
Figure 44. APAC Systemic Antihistamines Revenue Market Share by Regions in 2022
Figure 45. APAC Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 46. APAC Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 47. China Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Systemic Antihistamines Sales Market Share by Country in 2022
Figure 55. Europe Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 56. Europe Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 57. Europe Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 58. Germany Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Systemic Antihistamines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Systemic Antihistamines in 2022
Figure 73. Manufacturing Process Analysis of Systemic Antihistamines
Figure 74. Industry Chain Structure of Systemic Antihistamines
Figure 75. Channels of Distribution
Figure 76. Global Systemic Antihistamines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Systemic Antihistamines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Systemic Antihistamines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Systemic Antihistamines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Systemic Antihistamines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Systemic Antihistamines Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の全身性抗ヒスタミン薬市場予測 2023年-2029年] (コード:LP23DC00666)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全身性抗ヒスタミン薬市場予測 2023年-2029年]についてメールでお問い合わせ

世界の全身性抗ヒスタミン薬市場予測 2023年-2029年

【英語タイトル】Global Systemic Antihistamines Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC00666)・商品コード:LP23DC00666
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の全身性抗ヒスタミン薬市場」は、過去の販売実績から2022年の世界の全身性抗ヒスタミン薬の総販売量を検討し、2023年から2029年の予測される全身性抗ヒスタミン薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の全身性抗ヒスタミン薬の市場規模を掲載し、XXX百万米ドル規模の世界の全身性抗ヒスタミン薬市場の詳細な分析を提供します。本インサイトレポートは、世界の全身性抗ヒスタミン薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の全身性抗ヒスタミン薬市場における各社の独自のポジションをより深く理解するために、全身性抗ヒスタミン薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の全身性抗ヒスタミン薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。全身性抗ヒスタミン薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。全身性抗ヒスタミン薬の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。全身性抗ヒスタミン薬のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

全身性抗ヒスタミン薬の世界主要メーカーとしては、Bristol-Myers Squibb、 Baxter Healthcare、 Watson Laboratories、 Pfizer、 Nexgen Pharma、 Bayer、 Hennig Arzneimittel、 Novartis、 Apotex、 Teva、 Mylan、 Johnson and Johnson、 Neuraxpharm Arzneimittel、 Gedeon Richter、 Medrock Biotechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の全身性抗ヒスタミン薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では全身性抗ヒスタミン薬市場をセグメンテーションし、種類別 (先発医薬品、ジェネリック医薬品)、用途別 (病院、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:先発医薬品、ジェネリック医薬品

・用途別区分:病院、薬局、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の全身性抗ヒスタミン薬市場の10年間の市場状況・展望は?
・世界および地域別に見た全身性抗ヒスタミン薬市場成長の要因は何か?
・全身性抗ヒスタミン薬の市場機会はエンドマーケットの規模によってどのように変化するのか?
・全身性抗ヒスタミン薬のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:全身性抗ヒスタミン薬の年間販売量2018-2029、地域別現状・将来分析
・全身性抗ヒスタミン薬の種類別セグメント:先発医薬品、ジェネリック医薬品
・全身性抗ヒスタミン薬の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・全身性抗ヒスタミン薬の用途別セグメント:病院、薬局、その他
・全身性抗ヒスタミン薬の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の全身性抗ヒスタミン薬市場
・企業別のグローバル全身性抗ヒスタミン薬市場データ:2018-2023年の年間販売量、市場シェア
・企業別の全身性抗ヒスタミン薬の年間売上:2018-2023年の売上、市場シェア
・企業別の全身性抗ヒスタミン薬販売価格
・主要企業の全身性抗ヒスタミン薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

全身性抗ヒスタミン薬の地域別レビュー
・地域別の全身性抗ヒスタミン薬市場規模2018-2023:年間販売量、売上
・主要国別の全身性抗ヒスタミン薬市場規模2018-2023:年間販売量、売上
・南北アメリカの全身性抗ヒスタミン薬販売の成長
・アジア太平洋の全身性抗ヒスタミン薬販売の成長
・ヨーロッパの全身性抗ヒスタミン薬販売の成長
・中東・アフリカの全身性抗ヒスタミン薬販売の成長

南北アメリカ市場
・南北アメリカの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・南北アメリカの全身性抗ヒスタミン薬の種類別販売量
・南北アメリカの全身性抗ヒスタミン薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・アジア太平洋の全身性抗ヒスタミン薬の種類別販売量
・アジア太平洋の全身性抗ヒスタミン薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・ヨーロッパの全身性抗ヒスタミン薬の種類別販売量
・ヨーロッパの全身性抗ヒスタミン薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の全身性抗ヒスタミン薬販売量、売上(2018-2023)
・中東・アフリカの全身性抗ヒスタミン薬の種類別販売量
・中東・アフリカの全身性抗ヒスタミン薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・全身性抗ヒスタミン薬の製造コスト構造分析
・全身性抗ヒスタミン薬の製造プロセス分析
・全身性抗ヒスタミン薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・全身性抗ヒスタミン薬の主要なグローバル販売業者
・全身性抗ヒスタミン薬の主要なグローバル顧客

地域別の全身性抗ヒスタミン薬市場予測レビュー
・地域別の全身性抗ヒスタミン薬市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・全身性抗ヒスタミン薬の種類別市場規模予測
・全身性抗ヒスタミン薬の用途別市場規模予測

主要企業分析
Bristol-Myers Squibb、 Baxter Healthcare、 Watson Laboratories、 Pfizer、 Nexgen Pharma、 Bayer、 Hennig Arzneimittel、 Novartis、 Apotex、 Teva、 Mylan、 Johnson and Johnson、 Neuraxpharm Arzneimittel、 Gedeon Richter、 Medrock Biotech
・企業情報
・全身性抗ヒスタミン薬製品
・全身性抗ヒスタミン薬販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Systemic Antihistamines market size is projected to grow from US$ 25050 million in 2022 to US$ 38490 million in 2029; it is expected to grow at a CAGR of 6.3% from 2023 to 2029.
United States market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Antihistamines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Antihistamines players cover Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Bayer, Hennig Arzneimittel, Novartis and Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Systemic antihistamines are a class of medications that are taken orally or administered through injection and are designed to block the effects of histamine throughout the body. Histamine is a chemical released by the immune system in response to an allergen, and it contributes to the symptoms of allergic reactions such as itching, sneezing, runny nose, hives, and swelling.
LPI (LP Information)’ newest research report, the “Systemic Antihistamines Industry Forecast” looks at past sales and reviews total world Systemic Antihistamines sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Antihistamines sales for 2023 through 2029. With Systemic Antihistamines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Antihistamines industry.
This Insight Report provides a comprehensive analysis of the global Systemic Antihistamines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Antihistamines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Antihistamines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Antihistamines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Antihistamines.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Antihistamines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Original Drug
Generic Drugs
Segmentation by application
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Bayer
Hennig Arzneimittel
Novartis
Apotex
Teva
Mylan
Johnson and Johnson
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Systemic Antihistamines market?
What factors are driving Systemic Antihistamines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Systemic Antihistamines market opportunities vary by end market size?
How does Systemic Antihistamines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Systemic Antihistamines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Systemic Antihistamines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Systemic Antihistamines by Country/Region, 2018, 2022 & 2029
2.2 Systemic Antihistamines Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drugs
2.3 Systemic Antihistamines Sales by Type
2.3.1 Global Systemic Antihistamines Sales Market Share by Type (2018-2023)
2.3.2 Global Systemic Antihistamines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Systemic Antihistamines Sale Price by Type (2018-2023)
2.4 Systemic Antihistamines Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Systemic Antihistamines Sales by Application
2.5.1 Global Systemic Antihistamines Sale Market Share by Application (2018-2023)
2.5.2 Global Systemic Antihistamines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Systemic Antihistamines Sale Price by Application (2018-2023)
3 Global Systemic Antihistamines by Company
3.1 Global Systemic Antihistamines Breakdown Data by Company
3.1.1 Global Systemic Antihistamines Annual Sales by Company (2018-2023)
3.1.2 Global Systemic Antihistamines Sales Market Share by Company (2018-2023)
3.2 Global Systemic Antihistamines Annual Revenue by Company (2018-2023)
3.2.1 Global Systemic Antihistamines Revenue by Company (2018-2023)
3.2.2 Global Systemic Antihistamines Revenue Market Share by Company (2018-2023)
3.3 Global Systemic Antihistamines Sale Price by Company
3.4 Key Manufacturers Systemic Antihistamines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Systemic Antihistamines Product Location Distribution
3.4.2 Players Systemic Antihistamines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Systemic Antihistamines by Geographic Region
4.1 World Historic Systemic Antihistamines Market Size by Geographic Region (2018-2023)
4.1.1 Global Systemic Antihistamines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Systemic Antihistamines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Systemic Antihistamines Market Size by Country/Region (2018-2023)
4.2.1 Global Systemic Antihistamines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Systemic Antihistamines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Systemic Antihistamines Sales Growth
4.4 APAC Systemic Antihistamines Sales Growth
4.5 Europe Systemic Antihistamines Sales Growth
4.6 Middle East & Africa Systemic Antihistamines Sales Growth
5 Americas
5.1 Americas Systemic Antihistamines Sales by Country
5.1.1 Americas Systemic Antihistamines Sales by Country (2018-2023)
5.1.2 Americas Systemic Antihistamines Revenue by Country (2018-2023)
5.2 Americas Systemic Antihistamines Sales by Type
5.3 Americas Systemic Antihistamines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Systemic Antihistamines Sales by Region
6.1.1 APAC Systemic Antihistamines Sales by Region (2018-2023)
6.1.2 APAC Systemic Antihistamines Revenue by Region (2018-2023)
6.2 APAC Systemic Antihistamines Sales by Type
6.3 APAC Systemic Antihistamines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Systemic Antihistamines by Country
7.1.1 Europe Systemic Antihistamines Sales by Country (2018-2023)
7.1.2 Europe Systemic Antihistamines Revenue by Country (2018-2023)
7.2 Europe Systemic Antihistamines Sales by Type
7.3 Europe Systemic Antihistamines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Systemic Antihistamines by Country
8.1.1 Middle East & Africa Systemic Antihistamines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Systemic Antihistamines Revenue by Country (2018-2023)
8.2 Middle East & Africa Systemic Antihistamines Sales by Type
8.3 Middle East & Africa Systemic Antihistamines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Systemic Antihistamines
10.3 Manufacturing Process Analysis of Systemic Antihistamines
10.4 Industry Chain Structure of Systemic Antihistamines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Systemic Antihistamines Distributors
11.3 Systemic Antihistamines Customer
12 World Forecast Review for Systemic Antihistamines by Geographic Region
12.1 Global Systemic Antihistamines Market Size Forecast by Region
12.1.1 Global Systemic Antihistamines Forecast by Region (2024-2029)
12.1.2 Global Systemic Antihistamines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Systemic Antihistamines Forecast by Type
12.7 Global Systemic Antihistamines Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Systemic Antihistamines Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Baxter Healthcare
13.2.1 Baxter Healthcare Company Information
13.2.2 Baxter Healthcare Systemic Antihistamines Product Portfolios and Specifications
13.2.3 Baxter Healthcare Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Healthcare Main Business Overview
13.2.5 Baxter Healthcare Latest Developments
13.3 Watson Laboratories
13.3.1 Watson Laboratories Company Information
13.3.2 Watson Laboratories Systemic Antihistamines Product Portfolios and Specifications
13.3.3 Watson Laboratories Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Watson Laboratories Main Business Overview
13.3.5 Watson Laboratories Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Systemic Antihistamines Product Portfolios and Specifications
13.4.3 Pfizer Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Nexgen Pharma
13.5.1 Nexgen Pharma Company Information
13.5.2 Nexgen Pharma Systemic Antihistamines Product Portfolios and Specifications
13.5.3 Nexgen Pharma Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nexgen Pharma Main Business Overview
13.5.5 Nexgen Pharma Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Systemic Antihistamines Product Portfolios and Specifications
13.6.3 Bayer Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Hennig Arzneimittel
13.7.1 Hennig Arzneimittel Company Information
13.7.2 Hennig Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
13.7.3 Hennig Arzneimittel Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hennig Arzneimittel Main Business Overview
13.7.5 Hennig Arzneimittel Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Systemic Antihistamines Product Portfolios and Specifications
13.8.3 Novartis Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Systemic Antihistamines Product Portfolios and Specifications
13.9.3 Apotex Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Systemic Antihistamines Product Portfolios and Specifications
13.10.3 Teva Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Systemic Antihistamines Product Portfolios and Specifications
13.11.3 Mylan Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Johnson and Johnson
13.12.1 Johnson and Johnson Company Information
13.12.2 Johnson and Johnson Systemic Antihistamines Product Portfolios and Specifications
13.12.3 Johnson and Johnson Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Johnson and Johnson Main Business Overview
13.12.5 Johnson and Johnson Latest Developments
13.13 Neuraxpharm Arzneimittel
13.13.1 Neuraxpharm Arzneimittel Company Information
13.13.2 Neuraxpharm Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
13.13.3 Neuraxpharm Arzneimittel Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Neuraxpharm Arzneimittel Main Business Overview
13.13.5 Neuraxpharm Arzneimittel Latest Developments
13.14 Gedeon Richter
13.14.1 Gedeon Richter Company Information
13.14.2 Gedeon Richter Systemic Antihistamines Product Portfolios and Specifications
13.14.3 Gedeon Richter Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Gedeon Richter Main Business Overview
13.14.5 Gedeon Richter Latest Developments
13.15 Medrock Biotech
13.15.1 Medrock Biotech Company Information
13.15.2 Medrock Biotech Systemic Antihistamines Product Portfolios and Specifications
13.15.3 Medrock Biotech Systemic Antihistamines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Medrock Biotech Main Business Overview
13.15.5 Medrock Biotech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Systemic Antihistamines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Systemic Antihistamines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drugs
Table 5. Global Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 6. Global Systemic Antihistamines Sales Market Share by Type (2018-2023)
Table 7. Global Systemic Antihistamines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Systemic Antihistamines Revenue Market Share by Type (2018-2023)
Table 9. Global Systemic Antihistamines Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 11. Global Systemic Antihistamines Sales Market Share by Application (2018-2023)
Table 12. Global Systemic Antihistamines Revenue by Application (2018-2023)
Table 13. Global Systemic Antihistamines Revenue Market Share by Application (2018-2023)
Table 14. Global Systemic Antihistamines Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Systemic Antihistamines Sales by Company (2018-2023) & (K Units)
Table 16. Global Systemic Antihistamines Sales Market Share by Company (2018-2023)
Table 17. Global Systemic Antihistamines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Systemic Antihistamines Revenue Market Share by Company (2018-2023)
Table 19. Global Systemic Antihistamines Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Systemic Antihistamines Producing Area Distribution and Sales Area
Table 21. Players Systemic Antihistamines Products Offered
Table 22. Systemic Antihistamines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Systemic Antihistamines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Systemic Antihistamines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Systemic Antihistamines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Systemic Antihistamines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Systemic Antihistamines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Systemic Antihistamines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Systemic Antihistamines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Systemic Antihistamines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 35. Americas Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 37. Americas Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Systemic Antihistamines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Systemic Antihistamines Sales Market Share by Region (2018-2023)
Table 41. APAC Systemic Antihistamines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Systemic Antihistamines Revenue Market Share by Region (2018-2023)
Table 43. APAC Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 47. Europe Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 49. Europe Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Systemic Antihistamines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Systemic Antihistamines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Systemic Antihistamines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Systemic Antihistamines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Systemic Antihistamines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Systemic Antihistamines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Systemic Antihistamines
Table 58. Key Market Challenges & Risks of Systemic Antihistamines
Table 59. Key Industry Trends of Systemic Antihistamines
Table 60. Systemic Antihistamines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Systemic Antihistamines Distributors List
Table 63. Systemic Antihistamines Customer List
Table 64. Global Systemic Antihistamines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Systemic Antihistamines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Systemic Antihistamines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Systemic Antihistamines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Systemic Antihistamines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Systemic Antihistamines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Systemic Antihistamines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Systemic Antihistamines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Systemic Antihistamines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Systemic Antihistamines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bristol-Myers Squibb Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol-Myers Squibb Systemic Antihistamines Product Portfolios and Specifications
Table 80. Bristol-Myers Squibb Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. Baxter Healthcare Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Healthcare Systemic Antihistamines Product Portfolios and Specifications
Table 85. Baxter Healthcare Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter Healthcare Main Business
Table 87. Baxter Healthcare Latest Developments
Table 88. Watson Laboratories Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 89. Watson Laboratories Systemic Antihistamines Product Portfolios and Specifications
Table 90. Watson Laboratories Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Watson Laboratories Main Business
Table 92. Watson Laboratories Latest Developments
Table 93. Pfizer Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Systemic Antihistamines Product Portfolios and Specifications
Table 95. Pfizer Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Nexgen Pharma Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 99. Nexgen Pharma Systemic Antihistamines Product Portfolios and Specifications
Table 100. Nexgen Pharma Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Nexgen Pharma Main Business
Table 102. Nexgen Pharma Latest Developments
Table 103. Bayer Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Systemic Antihistamines Product Portfolios and Specifications
Table 105. Bayer Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Hennig Arzneimittel Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 109. Hennig Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
Table 110. Hennig Arzneimittel Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Hennig Arzneimittel Main Business
Table 112. Hennig Arzneimittel Latest Developments
Table 113. Novartis Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Systemic Antihistamines Product Portfolios and Specifications
Table 115. Novartis Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Apotex Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Systemic Antihistamines Product Portfolios and Specifications
Table 120. Apotex Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Apotex Main Business
Table 122. Apotex Latest Developments
Table 123. Teva Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Systemic Antihistamines Product Portfolios and Specifications
Table 125. Teva Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Teva Main Business
Table 127. Teva Latest Developments
Table 128. Mylan Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Systemic Antihistamines Product Portfolios and Specifications
Table 130. Mylan Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Mylan Main Business
Table 132. Mylan Latest Developments
Table 133. Johnson and Johnson Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 134. Johnson and Johnson Systemic Antihistamines Product Portfolios and Specifications
Table 135. Johnson and Johnson Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Johnson and Johnson Main Business
Table 137. Johnson and Johnson Latest Developments
Table 138. Neuraxpharm Arzneimittel Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 139. Neuraxpharm Arzneimittel Systemic Antihistamines Product Portfolios and Specifications
Table 140. Neuraxpharm Arzneimittel Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Neuraxpharm Arzneimittel Main Business
Table 142. Neuraxpharm Arzneimittel Latest Developments
Table 143. Gedeon Richter Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 144. Gedeon Richter Systemic Antihistamines Product Portfolios and Specifications
Table 145. Gedeon Richter Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Gedeon Richter Main Business
Table 147. Gedeon Richter Latest Developments
Table 148. Medrock Biotech Basic Information, Systemic Antihistamines Manufacturing Base, Sales Area and Its Competitors
Table 149. Medrock Biotech Systemic Antihistamines Product Portfolios and Specifications
Table 150. Medrock Biotech Systemic Antihistamines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Medrock Biotech Main Business
Table 152. Medrock Biotech Latest Developments
List of Figures
Figure 1. Picture of Systemic Antihistamines
Figure 2. Systemic Antihistamines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Systemic Antihistamines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Systemic Antihistamines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Systemic Antihistamines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drug
Figure 10. Product Picture of Generic Drugs
Figure 11. Global Systemic Antihistamines Sales Market Share by Type in 2022
Figure 12. Global Systemic Antihistamines Revenue Market Share by Type (2018-2023)
Figure 13. Systemic Antihistamines Consumed in Hospital
Figure 14. Global Systemic Antihistamines Market: Hospital (2018-2023) & (K Units)
Figure 15. Systemic Antihistamines Consumed in Retail Pharmacy
Figure 16. Global Systemic Antihistamines Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 17. Systemic Antihistamines Consumed in Other
Figure 18. Global Systemic Antihistamines Market: Other (2018-2023) & (K Units)
Figure 19. Global Systemic Antihistamines Sales Market Share by Application (2022)
Figure 20. Global Systemic Antihistamines Revenue Market Share by Application in 2022
Figure 21. Systemic Antihistamines Sales Market by Company in 2022 (K Units)
Figure 22. Global Systemic Antihistamines Sales Market Share by Company in 2022
Figure 23. Systemic Antihistamines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Systemic Antihistamines Revenue Market Share by Company in 2022
Figure 25. Global Systemic Antihistamines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Systemic Antihistamines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 28. Americas Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 30. APAC Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 32. Europe Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Systemic Antihistamines Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Systemic Antihistamines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Systemic Antihistamines Sales Market Share by Country in 2022
Figure 36. Americas Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 37. Americas Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 38. Americas Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 39. United States Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Systemic Antihistamines Sales Market Share by Region in 2022
Figure 44. APAC Systemic Antihistamines Revenue Market Share by Regions in 2022
Figure 45. APAC Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 46. APAC Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 47. China Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Systemic Antihistamines Sales Market Share by Country in 2022
Figure 55. Europe Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 56. Europe Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 57. Europe Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 58. Germany Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Systemic Antihistamines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Systemic Antihistamines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Systemic Antihistamines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Systemic Antihistamines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Systemic Antihistamines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Systemic Antihistamines in 2022
Figure 73. Manufacturing Process Analysis of Systemic Antihistamines
Figure 74. Industry Chain Structure of Systemic Antihistamines
Figure 75. Channels of Distribution
Figure 76. Global Systemic Antihistamines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Systemic Antihistamines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Systemic Antihistamines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Systemic Antihistamines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Systemic Antihistamines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Systemic Antihistamines Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の全身性抗ヒスタミン薬市場予測 2023年-2029年] (コード:LP23DC00666)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全身性抗ヒスタミン薬市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆